IRIX insider buys 1,500 shares at $1.37 — CFO Romeo R. Dizon

Iridex Corp (IRIX) insider purchase: Chief Financial Officer Romeo R. Dizon purchased 1,500 shares of Iridex common stock on 09/09/2025 at a price of $1.37 per share.

Rhea-AI Filing Summary

Iridex Corp (IRIX) insider purchase: Chief Financial Officer Romeo R. Dizon purchased 1,500 shares of Iridex common stock on 09/09/2025 at a price of $1.37 per share. Following the transaction, the reporting person beneficially owns 57,750 shares. The Form 4 was filed indicating the transaction code "P" and was signed by an attorney-in-fact on 09/10/2025.

Insights

Corporate Governance Expert

TL;DR: A routine small-dollar insider purchase was reported by the CFO, increasing direct ownership modestly.

The Form 4 shows the CFO acquired 1,500 shares at $1.37, bringing beneficial ownership to 57,750 shares. This filing is procedural and compliant with Section 16 reporting. The transaction code "P" denotes a purchase; no derivative or disposition activity is reported. Transaction size appears modest relative to typical institutional or company-wide stakes, and no additional context is provided in the filing.

Securities Compliance Analyst

TL;DR: Filing is complete and timely; signatures and required details are present.

The Form 4 includes issuer, reporting person, relationship (CFO), transaction date, price, number of shares acquired, and post-transaction beneficial ownership. The signature was executed by an attorney-in-fact and dated 09/10/2025, consistent with Section 16 timing requirements. No amendments or additional plan disclosures are indicated.

Insider Trade Summary

Net Buyer: 1,500 shares

Net Buy 1 txn

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 1,500 shs ($2K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,500	$1.37	$2K

Holdings After Transaction: Common Stock — 57,750 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IRIX report on the Form 4?

The Form 4 reports that CFO Romeo R. Dizon purchased 1,500 shares of Iridex common stock on 09/09/2025 at $1.37 per share.

How many shares does the reporting person own after the transaction?

Following the reported purchase the reporting person beneficially owns 57,750 shares of IRIX common stock.

What is the reporting person’s relationship to Iridex?

The reporting person, Romeo R. Dizon, is listed as Chief Financial Officer of Iridex and filed the Form 4 as an individual reporting person.

When was the Form 4 signed and by whom?

The Form 4 bears a signature from Nilo De Castro, Attorney-in-fact for Romeo R. Dizon dated 09/10/2025.

Does the Form 4 report any derivative transactions or dispositions?

No. The filing contains only a non-derivative purchase of common stock; Table II for derivatives and disposition entries are empty.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/10/2025 - 11:36 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		P		1,500	A	$1.37	57,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.